title: Antiviral treatment discontinuation among hepatitis C-infected individuals with thrombocytopenia.
authors.affiliation: NIHR Nottingham Digestive Diseases Biomedical Research Unit, University Hospital Nottingham, Nottingham, UK. will.irving@nottingham.ac.uk.
authors.forename: W L
authors.initials: WL
authors.lastname: Irving
authors.forename: K
authors.initials: K
authors.lastname: Grotzinger
authors.forename: D
authors.initials: D
authors.lastname: Theodore
authors.forename: D
authors.initials: D
authors.lastname: Demuth
authors.forename: M
authors.initials: M
authors.lastname: Rizzetto
authors.forename: A
authors.initials: A
authors.lastname: Roughley
authors.forename: U
authors.initials: U
authors.lastname: Forssen
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D004359:Drug Therapy, Combination / Q000009:adverse effects / Q000379:methods; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced*; D028761:Withholding Treatment
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin